Growth Metrics

Medpace Holdings (MEDP) Notes Payables (2022 - 2023)

Medpace Holdings (MEDP) has disclosed Notes Payables for 2 consecutive years, with $55.0 million as the latest value for Q2 2023.

  • For the quarter ending Q2 2023, Notes Payables fell 77.97% year-over-year to $55.0 million, compared with a TTM value of $55.0 million through Jun 2023, down 77.97%, and an annual FY2022 reading of $50.0 million, changed N/A over the prior year.
  • Notes Payables was $55.0 million for Q2 2023 at Medpace Holdings, down from $115.0 million in the prior quarter.
  • Across five years, Notes Payables topped out at $249.7 million in Q2 2022 and bottomed at $50.0 million in Q4 2022.